期刊文献+

一株携带新的突变ampC酶基因的弗劳地枸橼酸杆菌的研究

Gene sequence and biochemical characterization of ACT-1 from Citrobacter freundii,a new ampC-type plasmid-mediated β-lactamase with molecular variants
下载PDF
导出
摘要 目的探讨1株携带新的突变ampC基因的弗劳地枸橼酸杆菌分子生物学特征的改变及其与该突变位点的关系。方法对该株携带突变ampC基因的细菌克隆其编码基因后进行序列分析,并使用Southern杂交的方法定位该基因。测定其野生株、接合子与重组菌对12种抗菌药物的最低抑菌浓度(MICs),并对其编码蛋白进行等电聚焦电泳和酶动力学的检测。结果该细菌所产AmpC酶第147位氨基酸发生改变,由赖氨酸变为苏氨酸。Southern杂交结果表明,其编码基因位于质粒上。接合子、重组菌及野生株都对头孢西丁的MICs值均较高(>128mg/L)。等电聚焦电泳检测该AmpC酶的等电点为8.4。结论发现一株携带新的质粒介导ACT型ampC突变基因的弗劳地枸橼酸杆菌,其分子生物学特性与以往报道有一定区别。 Objective To determine the change of the characteristics of molecular biology in Citrobacter freundii which carring a new mutant gene, and find relationship with the change in mutation. Methods Clone the mutation ampC gene and made sequence analysis on it. Southern hybridization was done to detect the mutation gene whether located on plasmid. MICs was determine about the clincal stain, the transconjugant and the transformant by 12 antimicrobial agents. Results Sequence analysis revealed that the coding gene differed from blaACT-1 by four mutations, and one of them led to amino acid substitution : threonine for lysine at position 147. Southern hybridization showed that the coding gene was located on plasmid. All the clincal stain, the transconjugant and the transformant exhibi- ted high MICs to cefoxitin( 〉 128 mg/L). The isoelectric point (pI) of the AmpC β-lactamase was estimated to be 8.4. Conclusion We identify a new type of ampC gene which is mediated by plasmid, and its biochemical characterization is not similar with the same type reported before.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第2期158-161,共4页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金项目(编号:30772286) 安徽省自然科学基金项目(编号:070413110)
关键词 β内酰胺抗药性/遗传学 突变 β lactam resistance/gentics mutation Citrobacter freundii ampC gene
  • 相关文献

参考文献8

二级参考文献30

  • 1徐英春,王澎,陈民钧.286株肠杆菌科菌β-内酰胺酶及其耐药性的研究[J].中华医院感染学杂志,2004,14(4):447-449. 被引量:11
  • 2张冬梅,胡静,俞守义.肠聚集性大肠杆菌ybtE基因缺失突变株的构建[J].中国人兽共患病学报,2007,23(5):433-437. 被引量:2
  • 3Pitout JD, Sanders CC, Sanders WE. Antimicrobial resistance with focus on β-Lactam resistance in Gram-negative bacilli[J]. Am J Med,1997,103: 51-59
  • 4Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae[J]. Clin Infect Dis, 1998, 27(Suppl 1):s100-s106
  • 5Livermore DM. β-lactamases in laboratory and clinical resistance[J]. Clin Microb Rev, 1995,8:557-584
  • 6Bauernfeind A, Chong Y, Lee K. Plasmid-encoded AmpC β-lactamases: how far have we gone 10 years after the discovery?[J] Yonsei Med J, 1998, 39:520-525
  • 7Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamase among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center[J]. J Clin Microb, 2000, 38:1791-1796
  • 8National Committee for Clinical Laboratory Standard. Performance standards for antimicrobial susceptibility testing[S]; ninth informational supplement (M100-S9). NCCLS, Wayne, Pennsylvania, 1999
  • 9Mathew MJ, Harris AM, Marshall A, et al. The use of analytical isoelectric focusing for detection and identification of β-lactamases[J]. J Gen Microbiol, 1975,88:169-178
  • 10Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a laboratory manual [M]. 2nd ed, Cold Spring Harbor Laboratory Press

共引文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部